Compare Cassava Sciences Inc (FLNA) vs Oxford Lane Capital Corp (OXLC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Oxford Lane Capital Corp — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while Oxford Lane Capital Corp trades at $9.3 (market cap $909.61M). The key difference: Oxford Lane Capital Corp is far larger — about 19× Cassava Sciences Inc's market cap, and Oxford Lane Capital Corp pays a 25.76% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | OXLC | |
|---|---|---|
Market Cap | $47.75M | $909.61M |
Sector | Health | Financials |
52-Week High | $4.64 | $18.75 |
52-Week Low | $0.87 | $8.15 |
Enterprise Value | -$34.93M | — |
Dividend Yield | — | 25.76% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Oxford Lane Capital Corp
Oxford Lane Capital Corp. is a non-diversified, closed-end management investment company. Its primary investment objective is to achieve high current income, with a secondary objective of capital appreciation. The company primarily invests in equity and junior debt tranches of collateralized loan obligations (CLOs), which are pools of corporate loans. OXLC is known for its high-yield distribution policy and provides investors with leveraged exposure to the CLO market.
Read more on OXLC →
